---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-23-000079"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2023-11-20T23:59:59+00:00"
generated_at: "2026-06-07T23:24:12.901184+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics executes 1-for-40 reverse stock split to regain Nasdaq $1.00 minimum bid compliance

## Summary
- Reverse split at 1-for-40 ratio became effective at 4:01 p.m. ET on November 20, 2023.
- Purpose is to regain compliance with Nasdaq's $1.00 minimum closing price for continued listing.
- Fractional shares resulting from the split are rounded up to the nearest whole share.
- Percentage ownership unchanged for each stockholder except for fractional share adjustments.
- Class A common stock continues trading under symbol VTVT with new CUSIP 91835204.

## SEC filing metadata
- accession: 0001641489-23-000079
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2023-11-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000079/0001641489-23-000079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000079/vtvt-20231120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-23-000079
- JSON: https://secwatch.observer/filing/0001641489-23-000079.json
- Plain text: https://secwatch.observer/filing/0001641489-23-000079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.